Harvard Bioscience Inc expected to post earnings of 7cents a share - Earnings Preview

Harvard Bioscience

28/10/2022 17:07

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected
to show a
fall in quarterly revenue when it reports  results on November 1
(estimated). 
    * The Holliston Massachusetts-based  company is expected to
report
 a 2.6% decrease in revenue to $28.89 million from $29.66
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harvard Bioscience
Inc is
for earnings of 7 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $7​, above​ its last closing price of $2.52.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.04        0.06       0.05      Missed  -16.7
 Mar. 31 2022  0.05        0.05       0.04      Missed  -25
 Dec. 31 2021  0.08        0.10       0.08      Missed  -20​
 Sep. 30 2021  0.06        0.06       0.06      Met     0
 ​​Jun.        0.06        0.06       0.06      Met     -5.3
 30 2021                                                
 Mar. 31 2021  0.03        0.03       0.05      Beat    50​
 Dec. 31 2020              0.07       0.08      Beat    23.1
 Sep. 30 2020  0.03        0.04       0.04      Met     14.3
 This summary was machine generated October 28 at 16:07 GMT.  All
figures in US dollars  unless otherwise stated